| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/30/2011 | EP2301952A2 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 03/30/2011 | EP2301587A2 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 03/30/2011 | EP2301563A2 HSP20 peptides |
| 03/30/2011 | EP2300499A1 Anti-prion protein antibody fragment |
| 03/30/2011 | EP2300494A1 Anti-amyloid immunogenic compositions, methods and uses |
| 03/30/2011 | EP2300492A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 03/30/2011 | EP2300038A2 Improved peptide mediators of cholesterol efflux |
| 03/30/2011 | CN101993477A Preparation method of deoxy analog of Echinocandin B |
| 03/30/2011 | CN101993476A Casein active single peptide as well as preparation method and application thereof |
| 03/30/2011 | CN101993475A Synthesis method of full liquid-phase Eptifibatide |
| 03/30/2011 | CN101993474A Glaucocalyxin A derivatives with cyclic octapeptide structure as well as preparation method and application of glaucocalyxin A derivatives |
| 03/30/2011 | CN101991867A Multi-mode targeted probe for early hepatic fibrosis diagnosis and preparation method thereof |
| 03/30/2011 | CN101991848A Synthetic peptide vaccine for swine fever and application thereof |
| 03/30/2011 | CN101638681B Two aqueous phase extraction method for ocean pearl shell aminoglycoside |
| 03/30/2011 | CN101372505B Method for preparing desmopressin acetate |
| 03/29/2011 | US7915380 Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid |
| 03/29/2011 | US7915224 Method of preparing peptide |
| 03/29/2011 | US7915220 dextrorotatory amino acids; vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence; protect against amyloid-mediated neurotoxicity; have no similarities to the amino acid sequence in beta -amyloid regardless of the direction in which they are read |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | US7915008 Methods for isolation and analysis of sialylated and phosphorylated peptides |
| 03/29/2011 | US7914787 Provide inter alia a bi-specific antibody or antibody fragment having one arm that specifically binds a targeted tissue and one other arm that specifically binds a targetable conjugate that can be modified for use in a wide variety of diagnostic and therapeutic applications |
| 03/29/2011 | US7914780 Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
| 03/29/2011 | US7914778 Methods of treatment using IL-16 antagonist peptides |
| 03/29/2011 | CA2463544C Cross-linked glycopeptide-cephalosporin antibiotics |
| 03/29/2011 | CA2452845C Dye-sulfenates for dual phototherapy |
| 03/29/2011 | CA2435146C Formulation of boronic acid compounds |
| 03/29/2011 | CA2407514C Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/24/2011 | WO2011034931A2 Anti-fouling paints and coatings |
| 03/24/2011 | WO2011034580A2 Small peptide modulators of potassium channel trafficking |
| 03/24/2011 | WO2011032360A1 Momordica charantia peptide mc-jj2 and microwave promoted solid phase synthesis method thereof |
| 03/24/2011 | WO2011032359A1 Momordica charantia peptide mc-jj6 and microwave promoted solid phase synthesis method thereof |
| 03/24/2011 | WO2011008516A3 Methods and compositions for affecting the differentiation of clostridia in culture |
| 03/24/2011 | WO2010111652A3 Branched amphipathic oligo-peptides that self-assemble into vesicles |
| 03/24/2011 | WO2010111516A3 Compositions and methods for inhibiting biofilms |
| 03/24/2011 | WO2010096385A3 Methods and compositions for the treatment of autoimmune disease |
| 03/24/2011 | US20110071089 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
| 03/24/2011 | US20110071087 Polypeptides having modulatory effects on cells |
| 03/24/2011 | US20110071082 Long lasting anti-angiogenic peptides |
| 03/24/2011 | US20110071043 Methods For Characterizing Antibody Binding Affinity And Epitope Diversity in Food Allergy |
| 03/24/2011 | US20110070605 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 03/24/2011 | US20110070276 Bioactive keratin peptides |
| 03/24/2011 | US20110070255 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 03/24/2011 | US20110070253 Tumour-associated peptides binding to mhc molecules |
| 03/24/2011 | US20110070251 Cancer vaccine composition |
| 03/24/2011 | US20110070249 IMMUNIZING COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE AGAINST THE Beta-SECRETASE CLEAVAGE SITE OF AMYLOID PRECURSOR PROTEIN |
| 03/24/2011 | US20110070234 Np1 activity regulating elements useful for the production of drugs for the treatment or prevention of human neurodegenerative diseases, resulting drugs and use thereof |
| 03/24/2011 | US20110070208 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof |
| 03/24/2011 | US20110070185 Identification of antigenic peptides from multiple myeloma cells |
| 03/24/2011 | US20110070165 Multivalent constructs for therapeutic and diagnostic applications |
| 03/24/2011 | US20110070163 Cancer cell migration and cancer cell invasion inhibitor |
| 03/24/2011 | US20110070155 Anti-CD74 Immunoconjugates and Methods |
| 03/23/2011 | EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 03/23/2011 | EP2298792A2 Peptides targeted to protein kinase C isoforms and uses thereof |
| 03/23/2011 | EP2298791A1 Binding molecules for human factor VIII and factor VIII-like proteins |
| 03/23/2011 | EP2298790A1 Daptomycin analogs as antibacterial agents |
| 03/23/2011 | EP2297181A1 Synthetic pathway enzymes for the production of argyrins |
| 03/23/2011 | EP2297180A1 Mybl2 epitope peptides and vaccines containing the same |
| 03/23/2011 | EP2297179A1 Peptide analogues, particularly for the treatment of chronic pain |
| 03/23/2011 | EP2297178A2 Peptide analogs of alpha-melanocyte stimulating hormone |
| 03/23/2011 | EP2296685A1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 03/23/2011 | EP1940866B1 Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same |
| 03/23/2011 | EP1463529B9 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 03/23/2011 | EP1320377B1 Hla binding peptides and their uses |
| 03/23/2011 | CN101990547A Il-23 receptor antagonists and uses thereof |
| 03/23/2011 | CN101990545A Peptide analogues and conjugates thereof |
| 03/23/2011 | CN101987866A Staphylococcus aureus Efb protein C-end antigen epitope, as well as preparation method and usage thereof |
| 03/23/2011 | CN101987865A Antagonist of luteinizing hormone releasing hormone (LHRH) containing hydantoin structure |
| 03/23/2011 | CN101314614B Polypeptide combinative with PKR kinase structure field specificity and uses thereof |
| 03/22/2011 | US7910694 Homing peptides to receptors of heart vasculature |
| 03/22/2011 | US7910692 Immunogenic peptides and methods of use |
| 03/22/2011 | US7910088 Multivalent constructs for therapeutic and diagnostic applications |
| 03/17/2011 | WO2011031477A2 Nucleolin-binding peptides, nucleolin-binding lytic peptides, fusion constructs and methods of making and using same |
| 03/17/2011 | WO2011031460A2 Novel anti-inflammatory peptides that bind oxidized phospholipids |
| 03/17/2011 | WO2011030892A1 Novel substrate peptide for rho-kinase |
| 03/17/2011 | WO2011029946A1 A proteolytic product of histone h2a as a marker for cancer |
| 03/17/2011 | WO2011011342A9 Synthesis of desmopressin |
| 03/17/2011 | US20110065896 Polyether polyol dendron conjugates with effector molecules for biological targeting |
| 03/17/2011 | US20110065799 Urokinase inhibitors, production and use thereof |
| 03/17/2011 | US20110065652 Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction |
| 03/17/2011 | US20110065649 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 03/17/2011 | US20110065640 Anti-invasive and anti-angiogenic compositions |
| 03/17/2011 | US20110065600 Sequences associated with tdp-43 proteinopathies and methods of using the same |
| 03/17/2011 | US20110065134 Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies |
| 03/17/2011 | US20110065127 Detection of Degradative Enzymes and Biomolecules in Bodily Fluids |
| 03/17/2011 | US20110064759 Method for the Identification of Extracellular Domains of Epstein Barr Virus (EBV) Tumor-Associated Latent Membrane Proteins and for the Selection of Antibody Reagents Reactive Therewith |
| 03/17/2011 | US20110064741 Stable amyloid beta monomers and oligomers |
| 03/17/2011 | US20110064654 Prostate cancer diagnosis and treatment |
| 03/17/2011 | DE102005041616B4 Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen Melanoma-associated MHC class I-associated oligopeptides and coding for these polynucleotides and uses thereof |
| 03/17/2011 | CA2773737A1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| 03/16/2011 | EP2295568A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 03/16/2011 | EP2295444A2 Lipopeptides as antibacterial agents |
| 03/16/2011 | EP2295443A1 Tumor-associated peptides which bind to MHC molecules |
| 03/16/2011 | EP2295401A2 Deuterated hepatitis C protease inhibitors |
| 03/16/2011 | EP2295064A1 Monoclonal antibody therapy for pancreas cancer |
| 03/16/2011 | EP2294421A1 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 03/16/2011 | EP2294082A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 03/16/2011 | EP1978026B1 T-helper antigenic determinant (thd) peptides |
| 03/16/2011 | EP1436320B1 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 03/16/2011 | CN101381403B Alpha type conotoxin peptide derivates and use thereof |